Clorox (CLX) EBIT (2009 - 2026)

Clorox's EBIT history runs 18 years deep, the most recent figure standing at $466.0 million for Q1 2026.

• On a quarterly basis, EBIT rose 3.56% year-over-year to $466.0 million in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 8.75% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 12.14% from the prior year.
• EBIT advanced to $466.0 million in Q1 2026 per CLX's latest filing, from $431.0 million in the prior quarter.
• Across five years, EBIT topped out at $596.0 million in Q2 2025 and bottomed at $227.0 million in Q3 2023.
• The 5-year median for EBIT is $433.0 million (2024), against an average of $427.8 million.
• Across the five-year window, EBIT surged 118.06% in 2024 and sank 41.21% in 2025, its largest moves.
• Year by year, EBIT stood at $305.0 million in 2022, then soared by 67.87% to $512.0 million in 2023, then decreased by 16.6% to $427.0 million in 2024, then climbed by 0.94% to $431.0 million in 2025, then advanced by 8.12% to $466.0 million in 2026.
• Per Business Quant, the three latest CLX EBIT figures stand at $466.0 million (Q1 2026), $431.0 million (Q4 2025), and $291.0 million (Q3 2025).